Your browser doesn't support javascript.
loading
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma.
Salam, Rana; Saliou, Alexa; Bielle, Franck; Bertrand, Mathilde; Antoniewski, Christophe; Carpentier, Catherine; Alentorn, Agusti; Capelle, Laurent; Sanson, Marc; Huillard, Emmanuelle; Bellenger, Léa; Guégan, Justine; Le Roux, Isabelle.
Afiliação
  • Salam R; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Genetics and Development of Brain Tumors Team, Paris, France.
  • Saliou A; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Genetics and Development of Brain Tumors Team, Paris, France.
  • Bielle F; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Genetics and Development of Brain Tumors Team, Paris, France.
  • Bertrand M; AP-HP, Hôpital de la Pitié-Salpêtrière-Charles Foix, Département de Neuropathologie, Paris, France.
  • Antoniewski C; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Onconeurotek Tumor Bank, Paris, France.
  • Carpentier C; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Data Analysis Core Platform, Paris, France.
  • Alentorn A; Sorbonne Université, CNRS FR3631, Inserm US037, Institut de Biologie Paris Seine (IBPS), ARTbio Bioinformatics Analysis Facility, Paris, Institut Français de Bioinformatique (IFB), Paris, France.
  • Capelle L; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Genetics and Development of Brain Tumors Team, Paris, France.
  • Sanson M; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Genetics and Development of Brain Tumors Team, Paris, France.
  • Huillard E; AP-HP, Hôpital de la Pitié-Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.
  • Bellenger L; AP-HP, Hôpital de la Pitié-Salpêtrière-Charles Foix, Service de Neurochirurgie, Paris, France.
  • Guégan J; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Genetics and Development of Brain Tumors Team, Paris, France.
  • Le Roux I; Paris Brain Institute (ICM), Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Sorbonne Université, Onconeurotek Tumor Bank, Paris, France.
Nat Commun ; 14(1): 441, 2023 01 27.
Article em En | MEDLINE | ID: mdl-36707509
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França